Controlled ovarian hyperstimulation regimens: A review of the available evidence for clinical practice. Produced on behalf of the BFS Policy and Practice Committee

Human Fertility

Volumn 16, Issue 3, 2013, Pages 144-150

  Nardo, L G ^a   Bosch, E ^b   Lambalk, C B ^c   Gelbaya, T A ^d  

^a Reproductive Health Group ^*  (United Kingdom)

^b IVI Madrid   (Spain)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

Author keywords

COS; GnRH analogue; Gonadotrophins; Ovarian response

Indexed keywords

FOLLITROPIN; GONADORELIN; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; GONADORELIN DERIVATIVE; GONADOTROPIN; HUMAN MENOPAUSAL GONADOTROPIN; LUTEINIZING HORMONE; ORAL CONTRACEPTIVE AGENT; RECOMBINANT FOLLITROPIN; RECOMBINANT LUTEINIZING HORMONE;

ARTICLE; CLINICAL PRACTICE; CONTROLLED OVARIAN HYPERSTIMULATION; ENDOMETRIOSIS; EVIDENCE BASED PRACTICE; FERTILIZATION IN VITRO; HORMONE SUBSTITUTION; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; OVARIAN RESERVE; OVARY HYPERSTIMULATION; PREGNANCY RATE; SUPPLEMENTATION; TREATMENT OUTCOME;

EVIDENCE-BASED MEDICINE; FEMALE; FERTILITY; FERTILITY AGENTS, FEMALE; FERTILIZATION IN VITRO; GREAT BRITAIN; HUMANS; INFERTILITY, FEMALE; OVARIAN HYPERSTIMULATION SYNDROME; OVULATION INDUCTION; PRACTICE GUIDELINES AS TOPIC; SOCIETIES, SCIENTIFIC;

EID: 84884583845     PISSN: 14647273     EISSN: 17428149     Source Type: Journal    
DOI: 10.3109/14647273.2013.795385     Document Type: Article

References (25)

1. Abdelmassih, V., Salgueiro, R., Abdelmassih, C., & Carizza, C. (2006). Less miscarriage rate using LH (rLH) in nGnRH agonists long protocols. Human Reproduction, 21, i7.
2. Agrawal, R., Holmes, J., & Jacobs, H.S. (2000). Follicle-stimulating hormone or human menopausal gonadotropin for ovarian stimulation in in vitro fertilization cycles: a meta-analysis. Fertility & Sterility, 73, 338-343. (Pubitemid 30060370)
3. Al-Inany, H.G., Youssef, M.A., Aboulghar, M., Broekmans, F., Sterrenburg, M., Smit, J., & Abou-Setta, A.M. (2011). Gonadotrophin-releasing hormone antagonists for assisted reproductive technology. Cochrane Database of Systematic Reviews, 19, CD008046.
4. Al-Inany, H., Aboulghar, M.A., Mansour, R.T., & Serour, G.I. (2005). Optimizing GnRH antagonist administration: meta-analysis of fi xed versus fl exible protocol. Reproductive Biomedicine Online, 10, 567-570. (Pubitemid 40645532)
5. Al-Inany, H.G., Abou-Setta, A.M., Aboulghar, M.A., Mansour, R.T., & Serour, G.I. (2008). Effi cacy and safety of human menopausal gonadotrophins versus recombinant FSH: a meta analysis. Reproductive Biomedicine Online, 16, 81-88. (Pubitemid 351187376)
6. Andersen, A.N., Devroey, P., & Arce, J.C. (2006). Clinical outcome following stimulation with highly purifi ed hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial. Human Reproduction, 21, 3217-3227. (Pubitemid 44811626)
7. Balasch, J., Pe ñ arrubia, J., F ábregues, F., Vidal, E., Casamitjana, R., Manau, D., et al. (2003). Ovarian responses to recombinant FSH or HMG in normogonadotrophic women following pituitary desensitization by a depot GnRH agonist for assisted reproduction. Reproductive Biomedicine Online, 7, 35-42. (Pubitemid 36874404)
8. Balasch, J., Vidal, E., Pe ñ arrubia, J., Casamitjana, R., Carmona, F., Creus, M., et al. (2001). Suppression of LH during ovarian stimulation: analysing threshold values and eff ects on ovarian response and the outcome of assisted reproduction in downregulated women stimulated with recombinant FSH. Human Reproduction, 16, 1636-1643. (Pubitemid 32761742)
9. Balen, A.H., Hayden, C.J., & Rutherford, A.J. (1999). What are the clinical benefi ts of recombinant gonadotrophins Clinical effi cacy of recombinant gonadotrophins. Human Reproduction, 14, 1411-1417.
10. Banga, F.R., Lambalk, C.B., Huirne, J.A., van Wely, M., & van der Veen, F. (2011). Comparison of oral contraceptive pill pretreated GnRH antagonist versus long agonist protocols in IVF, a systematic review and meta-analysis. Human Reproduction, 26, i1-i353.
11. Barnhart, K., Dunsmoor-Su, R., & Coutifaris, C. (2002). Eff ect of endometriosis on in vitro fertilization. Fertility & Sterility, 77, 1148-1155. (Pubitemid 34626321)
12. Barrenetxea, G., Agirregoikoa, J.A., Jimeenez, M.R., de Larruzea, A.L., Ganzabal, T., & Carbonero, K. (2008). Ovarian response and pregnancy outcome in poor responder women: a randomized controlled trial on the eff ect of luteinizing hormone supplementation on in vitro fertilization cycles. Fertility & Sterility, 89, 546-553. (Pubitemid 351335051)
13. Biljan, M.M., Mahutte, N.G., Dean, N., Hemmings, R., Bissonnette, F., & Tan, S.L. (1998). Eff ects of pre-treatment with an oral contraceptive on the time required to achieve pituitary suppression with gonadotropin-releasing hormone analogues and on subsequent implantation and pregnancy rates. Fertility & Sterility, 70, 1063-1069. (Pubitemid 28546232)
14. Bosch, E., Vidal, C., Labarta, E., Remohi, J., & Pellicer, A. (2008). Highly purifi ed HMG versus recombinant FSH in ovarian hyperstimulation with GnRH antagonist-a randomised study. Human Reproduction, 23, 2346-2351.
15. Coomarasamy, A., Masoud, A., Cheema, D., van der Veen, F., Bossuyt, P.M.M., & van Wely, M. (2008). Urinary hMG versus recombinant FSH for controlled ovarian hyperstimulation following an agonist long down-regulation protocol in IVF or ICSI treatment: a systematic review and meta-analysis. Human Reproduction, 23, 310-315. (Pubitemid 351651234)
16. Daya, S., Gunby, J., Hughes, E.G., Collins, J.A., & Sagle, M.A. (1995). Follicle-stimulating hormone versus human menopausal gonadotropin for in vitro fertilization cycles: a meta-analysis. Fertility & Sterility, 64, 347-354.
17. De Placido, G., Alviggi, C., Perino, A., Strina, I., Lisi, F., Fasolino, A., et al.; Italian Collaborative Group on Recombinant Human Luteinizing Hormone. (2005). Recombinant human LH supplementation versus recombinant human FSH (rFSH) step-up protocol during controlled ovarian stimulation in normogonadotrophic women with initial inadequate ovarian response to rFSH. A multicentre, prospective, randomized controlled trial. Human Reproduction, 20, 390-396. (Pubitemid 40277606)
18. European and Israeli Study Group on Highly Purifi ed Menotrophin versus Recombinant Follicle-Stimulating Hormone. (2002). Effi cacy and safety of highly purifi ed menotrophins versus recombinant follicle-stimulating hormone in in vitro fertilization/intracytoplasmic sperm injection cycles: a randomized comparative trial. Fertility & Sterility, 78, 520-528.
19. European Recombinant Human, L.H. Study Group. (1998). Recombinant human luteinizing hormone (LH) to support recombinant human follicle stimulating hormone (FSH)-induced follicular development in LH-and FSH-defi cient anovulatory women: a dose-fi nding study. Journal of Clinical Endocrinology and Metabolism, 83, 1507-1514.
20. F ábreques, F., Creus, M., Pe ñ arrubia, J., Manau, D., Vanrell, J.A., & Balasch, J. (2006). Effect of recombinant human luteinizing hormone supplementation on ovarian stimulation and the implantation rate in down-regulated women of advanced reproductive age. Fertility & Sterility, 85, 925-931.
21. Ferraretti, A.P., Gianaroli, L., Magli, M.C., D ' Angelo, A., Farfalli, V., & Montanaro, N. (2004). Exogenous luteinizing hormone in controlled ovarian hyperstimulation for assisted reproduction techniques. Fertility & Sterility, 82, 1521-1526. (Pubitemid 39611376)
22. Filicori, M., Cognigni, G.E., Samara, A., Melappioni, S., Perri, T., Cantelli, B., et al. (2002). The use of LH activity to drive folliculogenesis: exploring uncharted territories in ovulation induction. Human Reproduction Update, 8, 543-557. (Pubitemid 35452780)
23. Filicori, M., Cognigni, G.E., Taraborrelli, S., Spettoli, D., Ciampaglia, W., & de Fatis, C.T. (1999). Low-dose human chorionic gonadotrophin therapy can improve sensitivity to exogenous follicle-stimulating hormone in patients with secondary amenorrhea. Fertility & Sterility, 72, 1118-1120.
24. Garcia-Velasco, J.A., Bermejo, A., Ruiz, F., Martinez-Salazar, J., Requena, A., & Pellicer, A. (2011). Cycle scheduling with oral contraceptive pills in the GnRH antagonist protocols the long protocol: a randomized, controlled trial. Fertility & Sterility, 96, 590-593.
25. Garcia-Velasco, J.A., Isaza, V., Requena, A., Mart ínez-Salazar, F.J., Landazábal, A., Remohí, J., et al. (2000). High doses of gonadotrophins combined with stop versus non-stop protocol of GnRH analogue administration in low responder IVF patients.